Evidence map›Paper›PMID 27129173›Full record

ArticleOncotarget2016

Characterization of preneoplastic and neoplastic rat mesothelial cell lines: the involvement of TETs, DNMTs, and 5-hydroxymethylcytosine.

David Roulois, Sophie Deshayes, Marie-Noëlle Guilly, Joëlle S Nader, Charly Liddell, Myriam Robard, Philippe Hulin, Amal Ouacher, Vanessa Le Martelot, Jean-François Fonteneau and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Biomarkers of tumor invasiveness in proteomics (Review).International journal of oncology · 2020
    Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

David RouloisCRCNA, Université d'Angers, Université de Nantes, Nantes, France.
Sophie DeshayesCRCNA, Université d'Angers, Université de Nantes, Nantes, France.
Marie-Noëlle GuillyCEA, DSV, iRCM, LCE, BP6, Fontenay aux Roses cedex, France.
Joëlle S NaderCRCNA, Université d'Angers, Université de Nantes, Nantes, France.
Charly LiddellCRCNA, Université d'Angers, Université de Nantes, Nantes, France.
Myriam RobardINSERM, Université d'Angers, Université de Nantes, Nantes, France.
Philippe HulinINSERM, Université d'Angers, Université de Nantes, Nantes, France.
Amal OuacherCRCNA, Université d'Angers, Université de Nantes, Nantes, France.
Vanessa Le MartelotCRCNA, Université d'Angers, Université de Nantes, Nantes, France.
Jean-François FonteneauCRCNA, Université d'Angers, Université de Nantes, Nantes, France.
Marc GrégoireCRCNA, Université d'Angers, Université de Nantes, Nantes, France.
Christophe BlanquartCRCNA, Université d'Angers, Université de Nantes, Nantes, France.
Daniel L PouliquenCRCNA, Université d'Angers, Université de Nantes, Nantes, France.
Nantes Université · FRCentre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers · FRCentre National de la Recherche Scientifique · FRInserm · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant mesothelioma (MM) is one of the worst cancers in terms of clinical outcome, urging the need to establish and characterize new preclinical tools for investigation of the tumorigenic process, improvement of early diagnosis and evaluation of new therapeutic strategies. For these purposes, we characterized a collection of 27 cell lines established from F344 rats, after 136 to 415 days of induction with crocidolite asbestos administered intraperitoneally. Four mesotheliomas were distinguished from 23 preneoplastic mesothelial cell lines (PN) according to their propensity to generate tumors after orthotopic transplantation into syngeneic rats, their growth pattern, and the expression profile of three genes. PN cell lines were further discriminated into groups / subgroups according to morphology in culture and the expression profiles of 14 additional genes. This approach was completed by analysis of positive and negative immunohistochemical MM markers in the four tumors, of karyotype alterations in the most aggressive MM cell line in comparison with a PN epithelioid cell line, and of human normal mesothelial and mesothelioma cells and a tissue array. Our results showed that both the rat and human MM cell lines shared in common a dramatic decrease in the relative expression of Cdkn2a and of epigenetic regulators, in comparison with PN and normal human mesothelial cells, respectively. In particular, we identified the involvement of the relative expression of the Ten-Eleven Translocation (TET) family of dioxygenases and Dnmt3a in relation to the 5-hydroxymethylcytosine level in malignant transformation and the acquisition of metastatic potential.

Indexed as

5-MethylcytosineAnimalsAsbestos, CrocidoliteBiomarkers, TumorCell Line, TumorCell MovementCell ProliferationCell Transformation, NeoplasticCyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p18DNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3AEpithelial CellsEpitheliumHumansKaryotype5-hydroxymethylcytosine5-MethylcytosineAsbestos, CrocidoliteBiomarkers, TumorCDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p18DNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3ADNMT3A protein, humanMixed Function OxygenasesProto-Oncogene ProteinsTET1 protein, humanDNMTsmesotheliomapreneoplastic mesothelial cellsratTETs

Identifiers

PMID27129173
PMCPMC5085183
OpenAlexW2342562028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.